BETH HORSEMAN: Open Payments
NPI 1316507205 · LEAVENWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 16 payments from 10 companies in 2025. Trend: 2023 $503 · 2024 $461 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Exact Sciences Corporation | 2 | $32 |
| Novo Nordisk Inc | 2 | $31 |
| PFIZER INC. | 2 | $27 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Verona Pharma, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: QULIPTA, UBRELVY, Wegovy, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Ohtuvayre, Dexcom G6 Transmitter, CAPLYTA.
Industry payments across KS — which companies pay providers there.
